Globus Medical Inc. (GMED) Gains Positive Attention Amid Improving Outlook
Globus Medical Inc. (NYSE:GMED) is one of the best medical technology stocks to invest in. On January 30, Needham upgraded its rating on Globus Medical Inc.
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sculptor Capital Daniel S. Och | 3,000,000 | $261,930,000 | -15% | 2.7% |
| 2. | Madison Avenue Partners Eli Samaha | 2,624,751 | $229,167,010 | +4% | 9.85% |
| 3. | Citadel Investment Group Ken Griffin | 2,539,396 | $221,714,665 | +2166% | 0.03% |
| 4. | Vestal Point Capital Ryan Wilder | 1,275,000 | $111,320,250 | +2% | 3.78% |
| 5. | Parsifal Capital Management David Zorub | 1,222,717 | $106,755,421 | +11% | 8.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | $33,136.20 | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | $32,947.50 | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | $33,740.00 | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $87.67 | 10,000 | $876,700.00 | 0 | 2026-02-12 | Filing | |
| $101.10 | 3,594 | $363,353.40 | 0 | 2026-01-08 | Filing | |
| $101.10 | 2,000 | $202,200.00 | 10,419 | 2026-01-08 | Filing | |
| $88.85 | 4,000 | $355,400.00 | 12,419 | 2025-12-12 | Filing | |
| $90.00 | 18,542 | $1,668,780.00 | 0 | 2025-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,549,455 | $921,072,916 | 0.01% | |
| 2. | 10,284,093 | $897,904,166 | 0.02% | |
| 3. | 7,294,878 | $636,916,203 | 0.29% | |
| 4. | 3,886,405 | $339,322,022 | 0.05% | |
| 5. | 3,463,845 | $302,428,307 | 0.01% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Here's What Lifted Globus Medical (GMED) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. U.S.
Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio
Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.
Globus Medical, Inc. (NYSE:GMED) Q3 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating
Globus Medical Inc. (NYSE:GMED) ranks among the best mid-cap stocks with huge upside potential. Following the publication of Globus Medical Inc.
12 Best Mid-Cap Stocks with Huge Upside Potential
The Commerce Department said on August 29 that core inflation, which does not include food and energy expenses, stood at a 2.9% seasonally adjusted annual rate based on the personal consumption expenditures...
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2025 Earnings Call. [Operator Instructions].
Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating
Globus Medical Inc. (NYSE:GMED) is one of the most undervalued stocks to buy and hold for 3 years.
Hedge Fund Resource Center